Related Experiment Videos
Cardiovascular health and depression
Alexander Glassman1, Peter A Shapiro, Daniel E Ford
1Columbia University, New York, NY 10032, USA.
Journal of Psychiatric Practice
|June 30, 2005
Summary
Depression elevates the risk of developing ischemic heart disease (IHD) and negatively impacts patient outcomes. This review explores safe and effective depression treatments for IHD patients, including psychosocial interventions.
Area of Science:
- Cardiology
- Psychiatry
- Clinical Medicine
Background:
- Depression is linked to increased risk and poorer prognosis of ischemic heart disease (IHD).
- Physicians express concerns regarding the safety of antidepressant use in IHD patients due to potential cardiac side effects and drug interactions.
Purpose of the Study:
- To review the evidence linking depression to IHD development and its role as a predictor of cardiac events.
- To evaluate the safety and efficacy of treating depression in patients with stable IHD and acute coronary syndromes.
- To discuss safety considerations, nonpharmacologic options, and quality of life impacts of antidepressant therapy in IHD.
Main Methods:
- Review of clinical and epidemiological studies.
- Expert roundtable discussion on risk, diagnosis, and treatment.
- Analysis of safety issues, drug interactions, and psychosocial interventions.
Main Results:
- Depression is a significant risk factor for developing IHD.
- Depression predicts adverse cardiac events in patients with existing IHD.
- Antidepressant therapy can be safe and effective in IHD patients, with careful consideration of interactions and individual patient factors.
Conclusions:
- Depression management is crucial for patients with IHD.
- A balanced approach considering pharmacologic and nonpharmacologic treatments is recommended.
- Clinical guidance is provided for managing depression post-myocardial infarction.